JESSICA EDWARDS: Open Payments
NPI 1588141782 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,891 in 93 payments from 17 companies in 2025. Trend: 2023 $1,828 · 2024 $1,341 · 2025 $1,891
Food & beverage: $1,781Education: $110
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 17 | $409 |
| ABBVIE INC. | 25 | $371 |
| GENZYME CORPORATION | 17 | $353 |
| Janssen Biotech, Inc. | 7 | $154 |
| Organon LLC | 4 | $99 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
| PFIZER INC. | 3 | $74 |
| Kerecis Limited | 2 | $69 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| Incyte Corporation | 3 | $57 |
Products named: NEMLUVIO, DUPIXENT, RINVOQ, SKYRIZI, TREMFYA, Kerecis SurgiClose, OPZELURA, VTAMA.
Industry payments across TX — which companies pay providers there.
